CareCloud, Inc. reports developments in AI-powered healthcare technology and revenue cycle management for medical practices and health systems. Company updates center on electronic health records, practice management, medical billing, patient experience management, business intelligence, digital health, and AI product portfolios including stratusAI, cirrusAI, and Marketware.
Recurring news themes include quarterly results, guidance, customer selections, product expansion into inpatient EHR, RCM, and analytics, and capital-structure actions involving credit facilities and preferred-stock matters. Updates also address cross-sell strategy, automation initiatives, conference presentations, and operational performance across its Healthcare IT and Medical Practice Management activities.
CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.
The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.
CareCloud (Nasdaq: CCLD) has completed the acquisition of Medsphere Systems Corporation, marking a significant expansion into the hospital IT market. The deal brings together Medsphere's extensive client base of over 600 healthcare facilities across 50 states with CareCloud's AI and R&D capabilities.
The acquisition includes Medsphere's comprehensive hospital IT ecosystem featuring CareVue (integrated inpatient EHR), RCM Cloud (revenue cycle management), Wellsoft (Emergency Department Information System), HealthLine (supply chain management), ChartLogic (ambulatory EHR), and managed IT services. This strategic move positions CareCloud to provide affordable, AI-enhanced healthcare technology solutions specifically targeted at small and mid-sized hospitals.
CareCloud (Nasdaq: CCLD) reported strong Q2 2025 financial results, marking its first quarter of positive GAAP EPS since going public in 2014. The company achieved GAAP net income of $2.9 million, a 73% increase from Q2 2024, and revenue of $27.4 million.
Key highlights include the launch of their AI Center of Excellence, scaling to 500 team members by year-end, and the completion of two acquisitions in 2025. The company reaffirmed its 2025 guidance, projecting revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and GAAP EPS of $0.10-0.13.
Year-to-date performance showed strong growth with GAAP net income up 238% to $4.9 million and free cash flow increasing 85% to $9.0 million compared to the same period last year.
CareCloud (Nasdaq: CCLD) has achieved ONC Health IT Certification for its electronic health record (EHR) platform specifically designed for Critical Access Hospitals (CAHs). This certification, granted on August 1, 2025, enables CareCloud to enter the $1.5 billion+ inpatient EHR market serving over 1,300 CAHs.
The company's AI-powered, cloud-based platform addresses the unique needs of rural hospitals, offering certified compliance, support for various workflows, and built-in AI tools. According to Black Book Research, over 50% of rural and CAHs plan to replace their legacy EHR systems by 2026, presenting a significant market opportunity for CareCloud's modern solution.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for July, August, and September 2025.
The company will pay $0.18229 per share monthly dividend for both Series A and B Preferred Stock. Series A holders will receive an additional $0.04688 per share payment due to historical rate adjustments. Both series carry an 8.75% annual dividend rate on the $25.00 per share liquidation preference. Dividends will be paid on August 15, September 15, and October 15, 2025.
Series A holders converted before March 6, 2025, are not eligible for these payments as they have already received their dividends in shares.CareCloud (Nasdaq: CCLD) has launched an AI-driven, fully integrated dermatology Electronic Health Record (EHR) system targeting the $9 billion U.S. dermatology services market. The cloud-based platform combines AI-powered documentation, advanced image management, and seamless integration with practice management, revenue cycle management (RCM), and telehealth services.
The comprehensive solution features AI-powered charting, customizable templates, advanced image management, integrated telehealth capabilities, optimized billing, and seamless interoperability with labs and pharmacies. The platform aims to streamline clinical workflows, enhance patient engagement, and improve financial outcomes for dermatology practices of all sizes.
CareCloud (Nasdaq: CCLD), a provider of AI-powered healthcare technology and revenue cycle management solutions, has scheduled its Q2 2025 earnings release for August 5, 2025, before market opening.
The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920.
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.
Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).
The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.